Skip to main content
FinSpry Logo
FinSpry
ANAB logo
ANAB
(NASDAQ)
AnaptysBio, Inc.
$57.68-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AnaptysBio (ANAB) Stock Price & Financial Analysis

AnaptysBio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$56.03 - $60.14
52-Week High$68.39
52-Week Low$15.40
Open$56.19
Volume611.62K
Average Volume (3M)611.62K
Market Cap1.81B
Shares Outstanding31.34M
Price to Sales (P/S)7.58
Price to Book (P/B)47.79
EV/EBITDA23.28
Revenue (TTM)234.60M
Net Income (TTM)-13.23M
Free Cash Flow (TTM)19.61M
EPS (TTM)$-0.42
Profit Margin-5.64%
Operating Margin20.42%
Return on Equity (ROE)-35.56%
Debt to Equity0.38
50-Day MA$55.75
200-Day MA$37.67
52-Week Change208.32%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AnaptysBio

What is the current stock price for ANAB?

As of the latest trading session, ANAB stock trades at $57.68. The 52-week range is $15.40–$68.39, with a day range of $56.03–$60.14.

What is the P/E ratio for ANAB?

The P/E ratio (Price-to-Earnings) for ANAB is shown in the Key Statistics section. This valuation metric helps compare AnaptysBio, Inc. to industry peers.

Does ANAB pay dividends?

AnaptysBio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ANAB?

Based on 11 analysts, the consensus for ANAB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ANAB?

AnaptysBio's market capitalization is $1.81B, classifying it as a small-cap company. AnaptysBio operates in the Healthcare sector within the Biotechnology industry.